GR20020100478A - Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης - Google Patents

Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης

Info

Publication number
GR20020100478A
GR20020100478A GR20020100478A GR2002100478A GR20020100478A GR 20020100478 A GR20020100478 A GR 20020100478A GR 20020100478 A GR20020100478 A GR 20020100478A GR 2002100478 A GR2002100478 A GR 2002100478A GR 20020100478 A GR20020100478 A GR 20020100478A
Authority
GR
Greece
Prior art keywords
valaciclivier
hydrochloride
anhydrous crystalline
same
anhydrous
Prior art date
Application number
GR20020100478A
Other languages
English (en)
Other versions
GR1004358B (el
Inventor
Helen S. Fain
David Alan Jones
Philip George Lake
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of GR20020100478A publication Critical patent/GR20020100478A/el
Publication of GR1004358B publication Critical patent/GR1004358B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

εφεύρεση σχετίζεται με άνυδρη κρυσταλλική βαλακυκλοβίρη υδροχλωρική, με φαρμακευτικά σκευάσματα που περιέχουν αυτή, με τη χρήση της στην ιατρική θεραπευτική και με μεθόδους για την παρασκευή αυτής. ΰ
GR20020100478A 2001-11-05 2002-11-05 Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης GR1004358B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33331301P 2001-11-05 2001-11-05
PCT/US2002/033926 WO2003040145A1 (en) 2001-11-05 2002-10-23 Anhydrous crystal form of valaciclovir hydrochloride

Publications (2)

Publication Number Publication Date
GR20020100478A true GR20020100478A (el) 2003-07-16
GR1004358B GR1004358B (el) 2003-10-07

Family

ID=23302261

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20020100478A GR1004358B (el) 2001-11-05 2002-11-05 Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης

Country Status (10)

Country Link
US (2) US20040197396A1 (el)
EP (1) EP1453834A1 (el)
JP (1) JP2005511612A (el)
AU (1) AU2002348022B2 (el)
CA (1) CA2465420A1 (el)
FR (1) FR2831885A1 (el)
GB (1) GB2383038B (el)
GR (1) GR1004358B (el)
IT (1) ITRM20020555A1 (el)
WO (1) WO2003040145A1 (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849736B2 (en) * 2001-09-07 2005-02-01 Teva Pharmaceutical Industries Ltd. Crystalline forms of valacyclovir hydrochloride
US20040197396A1 (en) * 2001-11-05 2004-10-07 Fain Helen S Anhydrous crystal form of valaciclovir hydrochloride
KR20070020149A (ko) * 2001-11-14 2007-02-16 테바 파마슈티컬 인더스트리즈 리미티드 발라시클로비르의 합성 및 정제 방법
US20050043329A1 (en) * 2002-09-06 2005-02-24 Shlomit Wizel Crystalline forms of valacyclovir hydrochloride
EP1575953A1 (en) * 2002-12-09 2005-09-21 Texcontor Etablissement Anhydrous crystalline form of valacyclovir hydrochloride
WO2004106338A1 (en) * 2003-05-30 2004-12-09 Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. Novel crystalline forms of valacyclovir hydrochloride
EP1638972A2 (en) * 2003-06-02 2006-03-29 Teva Pharmaceutical Industries Limited Novel crystalline forms of valacyclovir hydrochloride
CN1331471C (zh) * 2003-09-22 2007-08-15 陈云芳 盐酸万乃洛韦软胶囊组合物
EP1746098A1 (en) * 2005-07-21 2007-01-24 SOLMAG S.p.A. Valacyclovir polymorphs and a process for the preparation thereof
US20080167325A1 (en) * 2006-12-27 2008-07-10 Bs Praveen Kumar Valacyclovir compositions
JPWO2009031576A1 (ja) * 2007-09-03 2010-12-16 味の素株式会社 バラシクロビル塩酸塩結晶の製造方法
WO2011158252A1 (en) 2010-06-15 2011-12-22 Matrix Laboratories Ltd Process for the preparation of valacyclovir hydrochloride polymorphic form ii
CN105753868B (zh) * 2016-04-12 2017-08-01 浙江理工大学 一种盐酸伐昔洛韦的半水合物及其制备方法
CN112176011B (zh) * 2020-10-26 2022-10-18 辰欣药业股份有限公司 一种酶催化制备盐酸伐昔洛韦的方法
CN116754538B (zh) * 2023-06-15 2024-05-07 深圳市新阳唯康科技有限公司 一种阿昔洛韦软膏的晶型定量方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
GB8719367D0 (en) * 1987-08-15 1987-09-23 Wellcome Found Therapeutic compounds
GB9501178D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Guanine derivative
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
US6849736B2 (en) * 2001-09-07 2005-02-01 Teva Pharmaceutical Industries Ltd. Crystalline forms of valacyclovir hydrochloride
US20040197396A1 (en) * 2001-11-05 2004-10-07 Fain Helen S Anhydrous crystal form of valaciclovir hydrochloride
KR20070020149A (ko) * 2001-11-14 2007-02-16 테바 파마슈티컬 인더스트리즈 리미티드 발라시클로비르의 합성 및 정제 방법
US20050043329A1 (en) * 2002-09-06 2005-02-24 Shlomit Wizel Crystalline forms of valacyclovir hydrochloride
US20050059684A1 (en) * 2002-10-16 2005-03-17 Ben-Zion Dolitzky Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
EP1551838B1 (en) * 2002-10-16 2006-08-09 Teva Pharmaceutical Industries Ltd. Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
EP1575953A1 (en) * 2002-12-09 2005-09-21 Texcontor Etablissement Anhydrous crystalline form of valacyclovir hydrochloride
WO2004106338A1 (en) * 2003-05-30 2004-12-09 Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. Novel crystalline forms of valacyclovir hydrochloride
EP1638972A2 (en) * 2003-06-02 2006-03-29 Teva Pharmaceutical Industries Limited Novel crystalline forms of valacyclovir hydrochloride
WO2005073233A1 (en) * 2004-01-21 2005-08-11 Teva Pharmaceutical Industries Ltd. Process for the preparation of valacyclovir hydrochloride
EP1746098A1 (en) * 2005-07-21 2007-01-24 SOLMAG S.p.A. Valacyclovir polymorphs and a process for the preparation thereof
US20070112193A1 (en) * 2005-11-14 2007-05-17 Khunt Mayur D Valacyclovir process

Also Published As

Publication number Publication date
WO2003040145A1 (en) 2003-05-15
CA2465420A1 (en) 2003-05-15
GB2383038A (en) 2003-06-18
US20070093511A1 (en) 2007-04-26
EP1453834A1 (en) 2004-09-08
ITRM20020555A1 (it) 2003-05-06
ITRM20020555A0 (it) 2002-11-05
FR2831885A1 (fr) 2003-05-09
GR1004358B (el) 2003-10-07
AU2002348022B2 (en) 2006-06-15
GB0225771D0 (en) 2002-12-11
GB2383038B (en) 2005-01-19
JP2005511612A (ja) 2005-04-28
US20040197396A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
TW200508214A (en) Novel compounds
HUP0600141A3 (en) Low hygroscopic aripiprazole-anhydrate process for its preparation, pharmaceutical compositions containing it and its use
HUP0402264A3 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof
MY125978A (en) Admantane derivatives
IL173348A (en) Thienopyridine compounds, pharmaceuticals containing them and their use in the preparation of drugs
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
MY136520A (en) Novel compounds
HUP0402063A3 (en) Indole-2-carboxamides process for producing them, pharmaceutical compositions containing them and use thereof
HK1048990A1 (en) Novel compounds.
TW200510375A (en) New compounds
WO2004006858A3 (en) Compounds, compositions, and methods employing same
TW200505875A (en) Novel compounds
GB2352395A (en) Paroxetine methanesulfonate
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
PL370554A1 (en) New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
GB0111186D0 (en) Novel compounds
GR1004358B (el) Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης
IL162765A (en) Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
MXPA03010761A (es) Combinaciones farmaceuticas.
GB0109122D0 (en) Novel compounds
HRP20041092A2 (en) New pharmaceutical compositions containing filbanserin polymorph a
IL101358A0 (en) Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it
SG162614A1 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
MXPA04001419A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson.